Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2012
12/20/2012WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes
12/20/2012WO2012171793A1 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
12/20/2012WO2012171065A1 Treatment of allan-herndon-dudley syndrome with 3,5-diiodothyropropionic acid (ditpa).
12/20/2012US20120322850 Trpm-2 antisense therapy
12/20/2012US20120322822 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
12/20/2012US20120322798 Modulators of ATP-Binding Cassette Transporters
12/20/2012US20120322780 Steroidal compositions
12/20/2012US20120322778 Pharmaceutical compositions
12/20/2012US20120322735 Modified growth hormone polypeptides
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321632 Neutralizing prolactin receptor antibodies and their therapeutic use
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/20/2012CA2839511A1 Stable formulations of a hyaluronan-degrading enzyme
12/20/2012CA2839296A1 Methods for increasing insulin sensitivity and treating diabetes
12/20/2012CA2836804A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/19/2012EP2535342A1 Salt of fused heterocyclic derivative and crystal thereof
12/19/2012EP2535330A2 Iminopyridine derivative and use thereof
12/19/2012EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
12/19/2012EP2534167A2 Progesterone receptor antagonists
12/19/2012EP2534166A2 Progesterone receptor antagonists
12/19/2012EP2533798A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
12/19/2012CN102834406A Novel [3.2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
12/19/2012CN102834405A Progesterone receptor antagonists
12/19/2012CN102834109A Stable growth hormone compounds
12/19/2012CN102827286A Fusion protein of Exendin-4 and mutational human serum albumin, and preparation method of fusion protein
12/19/2012CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor
12/19/2012CN102823616A Plant pesticide for controlling longhorn beetle and use method thereof
12/18/2012US8333193 Dry powder inhalation system for transpulmonary administration
12/18/2012CA2392545C Pharmaceutical formulations for thyroid hormones
12/13/2012WO2012169579A1 Heterocyclic carboxylic acid ester derivative
12/13/2012US20120316249 Lycopene for the treatment for metabolic dysfunction
12/13/2012US20120316185 Cyclohexyl Amide Derivatives as CRF Receptor Antagonists
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120315244 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
12/13/2012US20120315217 Inverse agonists and neutral antagonists for the tsh receptor
12/13/2012CA2838824A1 Modulation of pancreatic beta cell proliferation
12/12/2012EP2532648A1 Locally active "soft" antiandrogens
12/12/2012EP2531516A2 Pregnane compounds condensed in position 16,17 with a pyrolidine ring with glucocorticoid activity
12/12/2012CN1484650B Urocortin proteins and uses thereof
12/12/2012CN102816081A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/12/2012CN102813688A Anti-insulin resistance adenosine monophosphate-activated protein kinase agonist
12/12/2012CN102020645B Pyrazolopyrimidinone derivatives and pharmaceutical salts, preparation method and application thereof
12/12/2012CN101679326B Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators
12/11/2012US8329680 Formulation
12/11/2012US8329679 Preformulation for tabletting natural mixtures of conjugated estrogens
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
12/11/2012CA2490580C Selective estrogen receptor modulators containing a naphthalene group
12/06/2012WO2012165398A1 Cycloalkyloxybiaryl compound
12/06/2012WO2012165314A1 Amide compound
12/06/2012WO2012164096A1 Process for the production of estetrol intermediates
12/06/2012WO2012163932A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
12/06/2012WO2012162796A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
12/06/2012US20120309839 Dosing regimes for trans-clomiphene
12/06/2012US20120309834 Novel uses of adipic acid
12/06/2012US20120309800 Metalloenzyme inhibitor compounds
12/06/2012US20120309786 3-amino-pyridine derivatives for the treatment of metabolic disorders
12/06/2012US20120309731 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
12/06/2012US20120309712 Compositions Comprising Dietary Fat Complexer and Methods for Their Use
12/06/2012US20120309696 Acth antagonist peptides
12/06/2012US20120309681 Treating or ameliorating some neuroendocrine disorders in male with help of prolactin
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308483 Treatment of Sleep Disturbances
12/06/2012CA2837736A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
12/06/2012CA2837359A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
12/06/2012CA2835981A1 Process for the production of estetrol intermediates
12/05/2012EP2530089A1 Neutralising prolactin receptor antibody Mat3 and its therapeutical use
12/05/2012EP2528612A1 Methods of treating glucose metabolism disorders
12/05/2012CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807612A Polypeptide fragment and preparation method and application thereof
12/05/2012CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor
12/05/2012CN102805778A Application of Chinese wolfberry root-bark aqueous extract to preparation of estrogen medicines
12/05/2012CN102805760A Application of twotooth achyranthes aqueous extract to preparation of estrogen medicines
12/05/2012CN102178685B Application of taurochenodeoxycholic acid in protection of adrenal gland function
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8323688 Pharmaceutical compositions comprising hGH for oral delivery
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2548323C Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
11/2012
11/29/2012WO2012162409A1 Biphenyl derivatives useful as glucagon receptor antagonists
11/29/2012US20120302620 Novel pyrone-indole derivatives and process for their preparation
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301470 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
11/29/2012CA2837088A1 Biphenyl derivatives useful as glucagon receptor antagonists
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2526940A2 Compositions containing enantiomeric equol, and methods for their making
11/28/2012EP2525834A1 Growth hormones with prolonged in-vivo efficacy
11/28/2012EP2525833A2 Stable growth hormone compounds
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102796077A Compound with diuretic effect
11/28/2012CN102793753A Health care conditioning oil
11/28/2012CN102342935B Berberine-phenylacetic acid derivative, pharmaceutically acceptable salt thereof and application thereof
11/27/2012US8318674 Local treatment of bone defects
11/22/2012WO2012158123A1 Compounds and methods for treating insulin resistance syndrome
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 290